Astrana Health, Inc.

NASDAQ:ASTH

Medical - Care Facilities

Healthcare
$29.65 +2.70%

+$1.03 today

Market cap
$1.47B
Beta
0.94
P/E (TTM)
63.3
EPS (TTM)
$0.62
52W Low $18.08High $40.13

Volume 0.52M

Average 0.51M

ASTH Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Astrana Health, Inc.NASDAQ: ASTH

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 49.05M shares rose 0.4% year over year, behind the +2.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.0% from the prior quarter. Over 3 fiscal years it compounded at +2.7% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +0.4% toward the trailing-twelve-month pace of +2.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
49.05M-1.0% QoQ
Last fiscal yearDec 2025
49.37M+2.4% YoY
LTMMar 2026
49.38M+2.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.4%——
1 year+2.4%——
3-year CAGR+2.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
49.37M USD
Year-over-year change
+2.4%
4-year CAGR
+2.1%

Weighted Avg Shares (Diluted) vs competitors

How ASTH compares with its peers on the latest reported figures

  • ASTH's LTM Mar 2026 weighted avg shares (diluted) of 49.38M shares is the 2nd highest of the 4 companies compared; the peer median is 16.59M shares.
  • Its year-over-year change of +2.4% is the 3rd highest of 4, against a peer median of +2.7%.
  • Over three fiscal years its annual growth of +2.7% compares with a peer median of +5.2%.
ASTH Competitors Peer median
Weighted Avg Shares (Diluted) for ASTH and competitors
Company Period LTM YoY 3-year CAGR
PRVAPrivia Health Group, Inc.LTM Jun 2026130.46M +2.7%+5.2%
ASTHAstrana Health, Inc.LTM Mar 202649.38M +2.4%+2.7%
AGLAgilon Health, Inc.LTM Mar 202616.59M +0.7%+0.5%
NUTXNutex Health, Inc.LTM Mar 20266.85M +30.2%+16.9%
Peer median (excluding ASTH) 16.59M+2.7%+5.2%

Competitors are the stored peer set for ASTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue773.92M1.14B1.39B2.03B3.18B
Cost of Revenue596.14M944.69M1.17B1.76B2.89B
Gross Profit177.77M199.48M214.96M271.39M295.78M
Gross Margin23.0%17.4%15.5%13.3%9.3%
Research & Development00000
Selling, General & Admin62.08M77.67M112.6M154.11M217.26M
Operating Expenses79.59M95.21M130.35M182.04M217.26M
Depreciation & Amortization17.52M17.54M17.75M27.93M45.75M
EBITDA100.66M112.08M123.69M141.84M135.28M
EBITDA Margin13.0%9.8%8.9%7.0%4.3%
Operating Income98.18M104.27M84.61M89.35M78.53M
Operating Margin12.7%9.1%6.1%4.4%2.5%
Interest Income1.57M1.98M14.21M14.51M12.16M
Interest Expense5.39M7.92M16.1M33.1M49.93M
Other Income / Expenses(20.43M)(17.65M)5.23M(8.53M)(38.92M)
Income Before Tax77.75M86.62M89.84M80.82M39.61M
Pre-Tax Margin10.0%7.6%6.5%4.0%1.2%
Income Tax Expense31.69M40.88M31.99M30.89M15.53M
Net Income68.92M45.17M60.72M43.15M22.49M
Net Margin8.9%3.9%4.4%2.1%0.7%
EPS (Basic)1.571.001.300.910.46
EPS (Diluted)1.520.991.290.900.46
Weighted Avg Shares43.83M44.97M46.71M47.69M49.08M
Weighted Avg Shares (Diluted)45.4M45.6M47.07M48.22M49.37M

Astrana Health, Inc.

NASDAQ:ASTH

Intrinsic Alpha fair value

Locked

Current Price

$29.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.